Antibody data
- Antibody Data
- Antigen structure
- References [0]
- Comments [0]
- Validations
- ELISA [1]
- Flow cytometry [2]
Submit
Validation data
Reference
Comment
Report error
- Product number
- Ab182746 - Provider product page
- Provider
- Aladdin Scientific
- Product name
- Telisotuzumab (anti-HGFR)
- Antibody type
- Recombinant
- Description
- Telisotuzumab (anti-HGFR) is a human recombinant bivalent antibody, a therapeutic antibody against the hepatocyte growth factor receptor (MET) that binds c-Met with high affinity and inhibits c-Met signaling.ÊTelisotuzumab (anti-HGFR) has antitumor activity.Purity>95% (SDS-PAGE&SEC)Endotoxin Level< 1.0EU/mg
- Reactivity
- Human
- Conjugate
- Unconjugated
- Vial size
- 100_g,10mg,1mg,5mg
- Concentration
- Lot by Lot
- Storage
- Store at -80_ for 24 months. Upon delivery aliquot. Avoid freeze/thaw cycle.
No comments: Submit comment
Supportive validation
- Submitted by
- Aladdin Scientific (provider)
- Main image
- Experimental details
- Telisotuzumab (anti-HGFR) (Ab182746) – ELISA Immobilized at 2.0 μg/mL can bind Telisotuzumab (anti-HGFR) (Ab182746) with the ECâ‚…â‚€ of 15.02 ng/mL.​
Supportive validation
- Submitted by
- Aladdin Scientific (provider)
- Main image
- Experimental details
- Telisotuzumab (anti-HGFR) (Ab182746) - Flow Cytometry Flow Cytometry analysis of Hela cells labelling HGFR (red) with Telisotuzumab (anti-HGFR) (Ab182746). Goat Anti-Human IgG (PE) (Ab175838) at a dilution of 1/1000 was used as the secondary antibody. Blue - Isotype control, human IgG (Ab170213). Black - Unlabelled control, cells without incubation with primary antibody.
- Submitted by
- Aladdin Scientific (provider)
- Main image
- Experimental details
- Telisotuzumab (anti-HGFR) (Ab182746) - Flow Cytometry Flow Cytometry analysis of A549 cells labelling HGFR (red) with Telisotuzumab (anti-HGFR) (Ab182746). Goat Anti-Human IgG (PE) (Ab175838) at a dilution of 1/1000 was used as the secondary antibody. Blue - Isotype control, human IgG (Ab170213). Black - Unlabelled control, cells without incubation with primary antibody.